<DOC>
	<DOCNO>NCT02790684</DOCNO>
	<brief_summary>This Phase 1 , open-label , single-center , non-randomized study assess mass balance single oral dose DS-8500a healthy male subject , 18 year ( ) 60 age , inclusive . The radiolabeled investigational medicinal product administer 12 healthy male subject 2 cohort 6 subject .</brief_summary>
	<brief_title>A Study Assessing Mass Balance Single Oral Dose 14C DS-8500a Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male subject 18 year ( ) 60 age , inclusive . Subjects must body mass index ( BMI ) 19 kg/m2 30 kg/m2 , inclusive ; , outside range , clinically significant agree Sponsor primary investigator ( PI ) . Subjects must good health determined Screening Day 1 ( Checkin ) assess medical history ( Screening ) , physical examination , vital sign , hematology , virology ( Screening ) , urinalysis . Laboratory result ( serum chemistry , hematology , urinalysis ) must outside normal range outside normal range , PI consider value clinically relevant . Subjects must agree participate investigational study end trial . Subjects must willing abstain grapefruit/grapefruit juice Seville oranges 10 first dose study medication throughout study . Subjects must willing refrain consume food beverage contain caffeine/xanthine alcohol start 24 h prior Checkin Day 1 . Subjects must able understand willing comply study requirement , willing allow collection blood , fecal , urine specimen . Subjects must give write informed consent participate study prior Screening . Consent document subject 's dated signature counter sign dated witness . The appropriate HIPAA authorization form must sign dated subject . Male subject must agree contraception ( condom spermicide ) addition female partner ( childbearing potential ) use another form contraception ( eg , intrauterine device , diaphragm spermicide , oral contraceptive , injectables , subdermal hormonal implant ) first dose 12 wk follow last dose administration . Also , male subject must donate sperm period 12 wk follow drug administration . Subject must history regular bowel movement ( define instance bowel movement least every without need medication ) . Subjects must willing eat entire meal snack provide stay research facility understand diet include food high fiber content possibly prune juice . Subjects receive prescription nonprescription ( overthecounter [ OTC ] ) systemic medication , topical medication , herbal supplement ( include St. John 's Wort [ hypericin ] ) within 14 prior dosing . Subjects participate clinical study involve administration investigational drug ( new chemical entity ) , market drug within 30 5 halflives investigational drug market drug prior dose . Subjects administer radiolabeled substance expose significant radiation ( eg , serial Xrays compute tomography ( CT ) scan , barium meal , occupational exposure etc ) within 12mo dose . Subjects involve occupation require monitor radiation exposure ( eg , Xray technician ) . Liver function ( aspartate aminotransferase [ AST ] , alanine aminotransferase [ ALT ] , total bilirubin [ TBL ] ) test result range &gt; upper limit normal Screening Enrollment Day 1 . Subjects estimate glomerular filtration rate ( eGFR ) ( use Modification Diet Renal Disease [ MDRD ] equation ) &lt; 90 mL/min . Subjects Fridericia 's correct QT interval ( QTcF ) interval duration &gt; 450 m , obtain average 3 ECG recorder 's measurement triplicate Screening ECGs ( 3 ECGs close succession least 1 min apart ) take least 10 min quiet rest supine position . Subjects abnormal waveform morphology ECGs Screening Day 1 would preclude accurate measurement time ventricular depolarization repolarization ( QT ) interval duration . Subject participate previous DS8500a study within 6mo prior screening . Subjects history significant allergic response drug except penicillin . Subjects history serious disorder , include cardiovascular , hematologic , pulmonary , hepatic , renal , gastrointestinal , connective tissue disease , uncontrolled endocrine/metabolic , oncologic ( within last 5 ) , neurologic , psychiatric disease , disorder may prevent successful completion study . Subjects consume 28 unit alcohol per wk ( one unit alcohol equal onehalf pint beer , 4 oz wine , 1 oz spirit ) subject significant history alcoholism drug/chemical abuse within 2 prior Screening . Subjects use tobacco product nicotinecontaining product ( include smoke cessation aid , gum patch ) within 6mo prior dosing . Subjects positive result test drug abuse , cotinine , alcohol Screening Day 1 . Subjects test positive HBsAg , antibody HCV HIV , Screening . Subject employ clinic . Subjects familial relationship another study participant . Subjects , opinion PI , participate study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>